Background and Objectives: Platelet-rich plasma (PRP) composition and activity vary with patient-related factors, medication exposure, and preparation procedures. We developed an adaptable manufacturing quality control score (QC-Score) framework and retained clinical outcomes as a secondary exploratory layer. Methods:...
Pedro Martí Picó, Diego Delgado, María Cayuela et al.· Pharmaceuticals· 0 citations
Background/Objectives: Platelet-rich plasma (PRP) has been extensively used in clinical practice to treat musculoskeletal (MSK) and spinal maladies. PRP applications and preparation methods focus on variables such as delivery technique, formulation, and device performance. Few PRP preparation methods consider the varia...
P. Everts, Luga Podesta, J. Fitzpatrick et al.· Journal of Clinical Medicine· 0 citations
To evaluate the anti-inflammatory and antioxidant effects of standard platelet-rich plasma (sPRP) and balanced protein-concentrate plasma (BPCP), which is a next-generation formulation enriched in platelet-derived and extraplatelet bioactive molecules, in an indirect co-culture model of primary human chondrocytes (hCh)...
Daniel Marijuan-Pinel, Jon Mercader-Ruiz, Xabier Sansinanea et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.